Plante Moran Financial Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Plante Moran Financial Advisors’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-310	Closed	-$31.9K	–	874
2023 Q2	$31.9K	Hold	310	–	–	﹤0.01%	367
2023 Q1	$33.8K	Buy	310 +254	+454%	+$28.1K	﹤0.01%	354
2022 Q4	$6.37K	Sell	56 -561	-91%	-$46.6K	﹤0.01%	638
2022 Q3	$38K	Buy	617 +365	+145%	+$25.5K	0.01%	349
2022 Q2	$20K	Buy	252 +26	+12%	+$2.46K	﹤0.01%	471
2022 Q1	$24K	Buy	226 +170	+304%	+$16.6K	﹤0.01%	464
2021 Q4	$6K	Hold	56	–	–	﹤0.01%	804
2021 Q3	$6K	Sell	56 -279	-83%	-$29K	﹤0.01%	774
2021 Q2	$31K	Buy	335 +200	+148%	+$18.4K	0.01%	472
2021 Q1	$12K	Sell	135 -56	-29%	-$4.73K	﹤0.01%	629
2020 Q4	$14K	Hold	191	–	–	﹤0.01%	587
2020 Q3	$15K	Buy	191 +56	+41%	+$3.85K	0.01%	555
2020 Q2	$8K	Hold	135	–	–	﹤0.01%	547
2020 Q1	$4K	Buy	+135	New	+$4.57K	﹤0.01%	611
2018 Q3	–	Sell	-1,500	Closed	-$25K	–	884
2018 Q2	$25K	Hold	1,500	–	–	0.01%	452
2018 Q1	$21K	Hold	1,500	–	–	0.01%	504
2017 Q4	$22K	Sell	1,500 -1,000	-40%	-$14K	0.01%	488
2017 Q3	$32K	Hold	2,500	–	–	0.02%	397
2017 Q2	$30K	Buy	+2,500	New	+$31.1K	0.02%	411

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Plante Moran Financial Advisors's HZNP Position: Q3 2023 in Review

Plante Moran Financial Advisors sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2023, closing a stake of 310 shares — an estimated $31.9K sold.

Plante Moran Financial Advisors first reported a position in HZNP in Q2 2017 and held it in 19 quarters. The position peaked at $38K in Q3 2022. 485 funds tracked by Wall St. Rank hold HZNP as of Q3 2023.

Plante Moran Financial Advisors reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Plante Moran Financial Advisors sold 310 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2023, an estimated $31.9K.
Plante Moran Financial Advisors first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and held it in 19 quarters.
Plante Moran Financial Advisors's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $38K in Q3 2022.
485 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2023.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2023, filed 7 Nov 2023.